Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the "2025 ...

Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

As part of a clinical trial, the National Center for Tumor Diseases (NCT/UCC) Dresden is now offering patients with ...

Pancreatic cancer vaccines eliminate disease in preclinical studies Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer ...

Breakthrough vaccine targets pancreatic cancer cells, showing promise in preclinical trials and paving the way for human testing.

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society. It typically causes no symptoms until it has already ...

Researchers at Case Western Reserve University and Cleveland Clinic are developing vaccines targeting pancreatic cancer that could eliminate the disease, leaving a patient cancer-free. So far, the ...

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society.